RECURRENT GLIOMA (GLIOBLASTOMA MULTIFORME)

Clinical trials for RECURRENT GLIOMA (GLIOBLASTOMA MULTIFORME) explained in plain language.

Never miss a new study

Get alerted when new RECURRENT GLIOMA (GLIOBLASTOMA MULTIFORME) trials appear

Sign up with your email to follow new studies for RECURRENT GLIOMA (GLIOBLASTOMA MULTIFORME), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for deadly brain cancer: experimental drug enters human trials

Disease control Not yet recruiting

This early-stage trial is testing a new drug called LMP744 in adults whose aggressive brain cancer (glioblastoma) has returned after standard treatment. The main goal is to see if the drug can shrink tumors and slow the cancer's progression. Participants will receive the drug thr…

Matched conditions: RECURRENT GLIOMA (GLIOBLASTOMA MULTIFORME)

Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control

Last updated Mar 16, 2026 15:23 UTC

RECURRENT GLIOMA (GLIOBLASTOMA MULTIFORME)

Get alerted when new RECURRENT GLIOMA (GLIOBLASTOMA MULTIFORME) trials appear

New hope for deadly brain cancer: experimental drug enters human trials